About the course

  • Course Design: Self-directed.

  • Duration: It will take you 6-8 hours to complete.

  • Eligibility for this course: Nurses and doctors working for the WCDHW.

  • Accreditation: This course is HPCSA accredited for 7 Clinical CPD points (Level 1) and WCDHW Nursing CPD accredited for 3 CPD points in Area of Practice.

  • Certification: Participants need 70% pass mark for final quiz.

  • Published: February 2026

Course outline

The following topics are covered in this course:

1. Basics of HIV

  • Definition and description of HIV
  • History of HIV
  • Epidemiology of HIV
  • Transmission of HIV


2. Theory of HIV infection and ART

  • HIV infection of the cell
  • Natural progression of HIV (WHO stages)
  • Anti-Retroviral Therapy (ART)
    • Reverse transcriptase inhibitors
    • Integrase inhibitors
    • Protease inhibitors
    • Capsid inhibitors


3. HIV prevention

  • Behavioural interventions to prevent HIV
  • Medical interventions to prevent HIV
    • Pre-exposure prophylaxis (PrEP)
    • Post-exposure prophylaxis (PEP)
    • Treatment as prevention (TasP)
    • Other medical interventions to prevent HIV
  • Stigma and discrimination


4. HIV routine care

  • Communicating a new diagnosis of HIV
  • HIV routine care at diagnosis & follow-up visits
  • TB Preventive Treatment (TPT)
  • ART initiation
    • Medication interactions with DTG
    • Side effects of TLD
  • Managing an unsuppressed viral load
    • ABCDE approach
    • Supporting the client taking long-term medication
    • Enhanced Adherence Counselling (EAC)


5. Opportunistic infections in HIV

  • Respiratory system OIs (TB, PJP)
  • Central nervous system OIs 
  • Gastro-intestinal OIs
  • Dermatological OIs


6. HIV and TB coinfection

  • Communicating with a client returning to care after disengaging
  • Tuberculosis (TB): in clients living with HIV
    • Close contacts
    • Targeted Universal TB testing (TUTT)
    • TB infection prevention and control
    • Urine LAM
    • HIV/TB coinfection
  • HIV routine care
    • WHO stage for clients with TB
    • Support the client taking long-term medication
    • Reasons to delay initiation of ART
    • Immune Reconstitution Inflammatory Syndrome (IRIS)
    • ART medication interactions with TB treatment


7. HIV and women's health 

  • Preconception care for couples with HIV
  • Cervical screen policy changes
  • Contraception for the client with HIV
  • Prevention of vertical transmission of HIV (VL monitoring during pregnancy)
  • Dolutegravir and pregnancy
    • Antenatal supplementation dosing options 
    • Medication interaction with metformin and antacids
  • Management of the client with HIV in labour and delivery
  • Management of the postnatal client with HIV
    • Integration of services with EPI schedule
    • Infant post-exposure prophylaxis
    • Infant feeding (breastfeeding and formula)


8. Special circumstances in HIV management

  • Case 1:
    • Urgent signs in a client with HIV
    • Immune Reconstitution Inflammatory Syndrome
    • When to start/restart ART
    • Kaposi sarcoma
  • Case 2:
    • Management of unsuppressed viral load
    • Resistance testing
    • Primary vs secondary resistance
    • Virological failure - TLD1 vs TLD2
  • Case 3:
    • Renal impairment and ART
    • Hepatitis B coinfection
    • Switching to TAF

 

9. Monitoring and evaluation: 

  • Documentation and reporting
  • Data collection tools
  • Adverse drug reaction (ADR) reporting
  • Challenges in recording and reporting


Western Cape Government Department of Health and Wellness
People Development Centre

Acknowledgements:

  • Knowledge Translation Unit